Published in November 2024, the Hepatitis A, B and C in New York City: 2023 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in New York City. Use this data to inform hepatitis intervention planning, advocate or seek grants for funding, and educate providers and patients.
Read the Hepatitis A, B and C in New York City: 2023 Annual Report.
New to this Report:
- Updated prevalence estimates for Hep B and C
- Ten-year trends in rates of people newly reported with chronic Hep B and C by sex, age, and race and ethnicity
- Hep B and C distribution maps by NYC City Council District and community navigation program sites
Monitoring Hepatitis Trends and Data
- 9,548 newly reported cases of Hep A, B, and C
- 6,947 newly reported cases of chronic Hep B, surpassing levels seen in 2019 before the COVID-19 pandemic
- 2,375 newly reported cases of chronic Hep C, a decline of 65% since 2014
Access to Care Highlights:
- Trained 911+ clinical providers to screen and treat Hep B and C
- Employed 13 Check Hep B bilingual patient navigators who reached 961 people with chronic Hep B and screened 1,026 people at risk for Hep B
- 14 syringe services programs served 22,693 New Yorkers and distributed 6,080,211 syringes
View the 2023 Hepatitis A, B and C Appendices here.
View the NYC Health Department press release here.
View previous NYC Hepatitis A, B and C Annual Reports from 2005 to present here.
For any questions about this report or to request a printed copy, email hep@health.nyc.gov.
Last Updated on February 21, 2025 by HepFree NYC
